YD Bio (YDES) Shares Outstanding (Entity) (2024 - 2025)
YD Bio (YDES) reported Shares Outstanding (Entity) of 70.79 million for the quarter ended Dec 31, 2025, up 9.4% from 64.73 million a year earlier.
Powered by 
Analysis
YD Bio (YDES) Shares Outstanding (Entity) (2024 - 2025) Analysis & Trends
- By year, Shares Outstanding (Entity) came in at 64.73 million in the year ended Dec 31, 2024 (unchanged) and 64.73 million in the year ended Dec 31, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.70 Bn |
| 10 | YD Bio | 380.97 Mn | 368.70 Mn | - | - |
API Access
YD Bio Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=YDES&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "YDES", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=YDES&period=max&api_key=YOUR_API_KEY");
const data = await res.json();